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Platformization has emerged as a dominant infrastructural and 
economic model of the social web (Helmond 2015, Ozgun 2018) 
bringing various market actors together and enabling interactions 
among these actors, shaping the web’s participatory nature (Gillespie 
2010) and sociality (Van Dijck 2013) in unprecedented ways and 
paving ways for citizen empowerment and democratization (Beer 
2009). Platform organizations rely on data provided by users to extract 
value and make profit via the datafication of our everyday life. In 
healthcare, platform organizations bring together diverse market actors 
for partnership for the creation and distribution of aggregate patient 
data, on which the market can act and deliver outcomes that are 
potentially beneficial for the parties involved. In addition, we observe 
the boundary of scientific expert versus layperson becoming 
increasingly blurred through the emergence of participatory medicine 
and citizen science movement enabled by new technologies and digital 
platforms. Patient generated medical research and knowledge enabled 
by these platforms lead to a new and democratized knowledge 
production within the medical sciences (Gibbons and Novas 2008). 
Patients engage in self and collective quantification and tracking of 
health data. Healthcare stakeholders such as governments, 
pharmaceuticals and research institutions can gain access to patient 
generated data for drug discovery and development, confirmation of 
randomized clinical trials, and recruitment of patients from these 
communities via these platforms.  
In order to articulate how such platformization of patient/citizen-
led medical research and disease control is organized and sustained, I 
turn to the Foucauldian notion of biopower and Rabinow’s concept of 
biosociality to then draw attention to what I call biosocial surveillance, 
which is becoming increasingly relevant in today’s risk society. Indeed, 
global exacerbation of the Covid-19 pandemic pushes us to rethink the 
conventional slow-moving medical discovery and surveillance 
processes driven by dominant macro-institutions; indeed, the patient-
citizen is increasingly becoming an active partner of the surveillance of 
this pandemic together with macro institutions. Biosocial surveillance is 
an outcome of the desire to assemble technologies and surveillance 
practices in order to increase the degree of surveillance capacity 
(Haggerty and Ericson 2000) through platforms for a more (hopefully) 
democratized and accessible patient care and citizen-led medical 
research. State enforced coronavirus quarantines around the world 
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also highlight the ever-growing potential of digital biosociality through 
platforms. 
Digital Biopower  
Foucault (1990: 139-140) first coined the term biopower in The History 
of Sexuality to refer to the emergence of various disciplines or 
institutions (e.g., universities, secondary schools, barracks), hence the 
“explosion of numerous diverse techniques for achieving the 
subjugation of bodies and the control of populations”.  In general, 
biopower, a new modality of power, reflects the nation state’s concerns 
with prolonging the life of populations and taking control of bodies 
through regulatory controls (control of populations) and disciplinary 
techniques (control of the individual body) to gain a normal, healthy 
body. Technological advancements of the networked society further 
stimulate surveillance techniques to control populations, thus the 
excess of biopower in a panoptic gaze (Foucault 2003). In the 
Foucauldian notion of power, biopower is not considered a repressive 
form of power but one that acts on and through individuals’ actions, 
desires, motives, bodies, and produces relationships by giving them a 
sense of freedom and control (Foucault 1980). Thus, biopower 
incorporates the seamless coalescence of disciplinary techniques for 
optimizing and managing bodies (Hiley 1984). Indeed, modern 
medicine as a disciplinary entity has long had the utmost influence on 
shaping our bodies as a means to maximize health, prevent death, and 
regiment our subjectivities. Nation state and health institutions were the 
sole legitimate locus of control over the patient body and health and 
sharing of private health data, and they employed ‘security’ and ‘fear’ 
as discourses of power in this process (Epstein 2006) in order to 
sensitize people for privacy.  
With advancements in new technologies, new forms of biopower 
emerge. For example, when the Covid pandemic emerged, in order to 
limit the spread of the virus, governments benefited from digital 
technologies to engage in contact tracing and track individuals from 
phone data. Trace-together application in Singapore enabled health 
authorities to contact those who might have been exposed to the virus 
(https://www.tracetogether.gov.sg). For those who do not use such 
mobile apps, trace together token is distributed to citizens, which is a 
physical device that exchanges Bluetooth signals with other tokens and 
mobile apps nearby in order to enable digital contact tracing. 
Interestingly, the government promotes it as voluntary and community 
driven contact tracing and responsibilizing citizens to act to protect 
themselves, their loved ones and their communities who may be at risk 
and provide guidance to circumvent the effects of the virus. QR code 
technology is also used in Russia and China to track citizens and 
enforce quarantining. Despite all these questionable uses of digital 
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technologies by nation states (Kitchin 2020), many governments have 
exposed their vulnerability and insufficiency when fighting with the 
virus. As the influence of biopower to control the spread of Covid 
weakens, governments turn not only to their citizens, but also 
communities and market/alternative market institutions to collectively 
fight with the virus and manage patient care. 
Towards Digital Biosociality and the Rise of Biosocial 
Surveillance 
In biopower, the patient body was treated as a medium through which 
the state and healthcare providers perform their regulatory and overly 
deterministic actions to provide unidirectional care to the patient. 
Moving beyond the controlling and dominating aspirations of biopower, 
the healthcare market now encounters the rising participatory and 
productive capabilities of patient-citizens and healthcare actors on 
platforms, and the new sociocultural, sociomaterial, and communal 
production of medicine and control of diseases in the healthcare 
system. As new technologies and digital platforms exhibit potentials to 
change the dynamics of government control and dominant expertise 
system in healthcare, patients – once dominated and dormant – are 
beginning to be increasingly involved in their own and others’ care in 
collaboration with governmental agencies and platform businesses for 
vaccine discovery. A new kind of shared and user-driven medicine is 
on the rise with the increased creative efforts and active engagement 
of patients in the medical knowledge generation process.  
In healthcare platforms such as PatientsLikeMe, 23andMe, and 
Raremark, patients contribute to the generation of collective medical 
knowledge and clinical research together with other patients, 
pharmaceuticals, physicians/researchers, and government. These 
platforms create a community of diverse healthcare actors and 
challenge the conventional ways of practicing medicine and conducting 
medical research by conventional medical experts. The conventional 
ways treat physicians and their patients as well as other healthcare 
market actors such as governments, pharmaceuticals and research 
institutions as alienated and distinct entities. For example, 
PatientsLikeMe (PLM) – as a Medicine 2.0 platform organization – 
(re)connects market actors to each other for medical research and 
knowledge generation, reinforces collaboration among these actors by 
combining patient generated data and expert medicine in the design of 
medical research and generation of medical knowledge, and enabling 
proactive relations with healthcare actors in and beyond its platform. 
23andMe platform advances genetics research with direct and 
increased patient inclusion in this democratized and accessible 
research process as well as sharing of self-reported genetics data by 
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patients with other healthcare actors on the platform. Raremark is an 
online platform of patients with rare diseases, and it serves to raise 
knowledge and awareness about such diseases through building a 
research network of rare disease patients and their families, and inform 
pharmaceutical companies about patient generated data to deliver fast 
and smarter innovative solutions and enable them to have access to a 
large rare disease patient pool to recruit them for clinical trials. During 
the Covid pandemic patients and healthcare providers have 
collaborated for developing and refining the Covid symptoms tracker on 
PLM, and then used this surveillance tool for reporting symptoms and 
comparing treatments received. Platforms enable these initiatives and 
speed up the pandemic tracking process inclusive of individual patients 
for the discovery of vaccines. Patient-citizen generated data on health 
platforms through these surveillance tools are a real-time response to 
fast-evolving global sanitary crises and early detection (Joshi et al. 
2020) and monitoring the spreading (Knight 2020) of the virus.  
In order to articulate the roles and relations among healthcare 
actors for tracking and controlling the effects of Covid, I refer to 
Rabinow’s (1996: 102) concept of “biosociality”, which puts emphasis 
on the new ways of engagement of individuals in sharing experiences 
and changing their relations to their social and professional 
environments, and their lifestyles.  Biosociality allows for rethinking the 
emergence and development of new socialities as our knowledge and 
understanding of diseases and medical data transform via new 
inclusive ways of management of patient datafication and care. 
Biosocial collectivities – gathered around a shared somatic experience 
– bring about new configurations of roles and relations among 
healthcare actors (Rabinow 1996; Rose 2007), a new kind of solidarity 
against the pandemic and for medical research and knowledge 
generation. Patient care and corporeal experiences are now 
(re)designed by new forms of intervention with other patients, medical 
experts, government agencies, researchers and the like; thereby 
initiating new forms of biosociality for disease control and prevention. 
Patient body is no longer an object of one-way surveillance and 
domination by the superior medical gaze and government control. 
Platforms enable patients to not only exert control over their and others 
care and bodies but also actively participate in clinical research, a 
domain in which the dominant experts were clinicians and academics, 
who conducted and validated their research with total control over the 
scientific research process.   
What we observe now is that patients and other healthcare 
actors engage jointly in biosocial surveillance enabled by platforms. 
This entails a systematic, social, and real-time process that involves 
constant monitoring, collection, analysis, aggregation, and 
dissemination of shared private health data and the resulting discovery 
4
Markets, Globalization & Development Review, Vol. 5 [2020], No. 3, Art. 2
https://digitalcommons.uri.edu/mgdr/vol5/iss3/2
DOI: 10.23860/MGDR-2020-05-03-02
of medical knowledge and management of patient care through 
communities of patients, doctors, researchers, pharmaceuticals 
government agencies and the like. The rise of biosocial surveillance 
through digital biosocialities (Rabinow 1996) shifts the responsibility of 
state institutions for surveilling populations to new healthcare platforms 
and patient communities, and surveillance becomes concurrently as 
much a caring practice as a disciplinary tool (Lyon 2006). When 
governments and healthcare institutions fall short on controlling the 
spread of the virus and ensuring patient health, alternative market 
solutions and open source initiatives emerge to engage in biosocial 
surveillance and support healthcare institutions. For example, the open 
source project CoEpi (Community Epidemiology in Action) “is a 
privacy-first system for anonymous Bluetooth proximity-based 
exposure alerting based on voluntary symptom sharing” 
(https://www.coepi.org). Acknowledging the gap between the 
government and individual actions such as hygiene control and 
physical distancing, these open source platform initiatives aim to close 
this gap using smart phone technologies and cloud computing, and 
enable people to anonymously track their own contacts, and keep 
themselves and their immediate environments in the know concerning 
elevated virus risks and symptoms and compare their symptoms with 
others infected with the virus.  
Moreover, wearable technologies such as Immutouch 
(https://immutouch.com) also take part in this biosocial surveillance in 
order to prevent the spread of the virus and enable users to surveil and 
control their bodily movements not only for self-care but also for the 
care of communities. This smartband technology vibrates and warns 
users whenever they attempt to touch their faces, hence prevents the 
spread of germs and viruses. Such self-tracking practices via wearable 
technologies are manifestations of body biopolitics that responsibilize 
patient citizens to be in charge of their bodies through the neoliberal 
ethos of self-care and empowerment (Lupton 2014), and participatory 
surveillance (Albrechtslund, 2008) rather than coercive surveillance 
techniques (Ajana 2017) by the state and the market. 
  Another example of a biosocial community that emerged during 
the Covid crisis in order to make up for the insufficiencies of 
governments and health institutions for managing emergency patient 
care is Coronavirusmakers1. This open source Do-it-Yourself (DIY) 
maker community from Spain has designed masks and mechanical 
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technology to provide fast solutions to health institutions that were in 
urgent need of medical equipment to provide vital care for patients 
admitted to hospital emergency rooms and the market lacked the 
manufacturing capacity for such lifesaving equipment in a short time. 
Many citizens (including doctors from different countries, engineers, 
students, teachers, business people) got together on this platform to 
brainstorm and experiment designs and ideas, build prototypes and 
use 3D printing to produce the equipment and respond to the 
worldwide medical shortage. 
Concluding Remarks on the Limits of Biosocial 
Surveillance 
Platformization of Covid further responsibilizes the patient citizen in 
generating data and tracking the virus, hence giving a sense of control 
to the patient over medical data generation and patient care through 
digital biosocial communities. Platforms as dominant organizational 
forms, however, extract value and make profit on vast amounts of 
patient data under emerging forms of surveillance capitalism (Zuboff 
2019). Critical scholars draw attention to the dangers of pervasive 
surveillance capitalism, and crises like Covid perpetuate socio-
technical vulnerability due to the rising infodemic (i.e., spread of 
misinformation) aggravated through digital platforms (Donovan 2020) 
and intensify racial inequalities (French and Monahan 2020). Patients 
are desperately seeking for solutions to combat the virus on social 
media platforms, and they fall prey to any solution, reliable or not. Such 
manipulation of vulnerability calls for systematic control of infodemic 
through sorting, ranking and prioritizing critical and reliable data 
(Donovan 2020). Kitchin (2020) also lists critical issues related to the 
efficiency and effectiveness of digital technologies to control the spread 
of Covid, which relate to civil liberties, technical and data quality and 
manipulation issues, and further propagation of the underpinnings and 
practices of surveillance capitalism. The dominant reductionist 
discourse of privacy as an individual right versus solidarity for public 
good in surveillance capitalism aims to legitimize the commercialization 
and exploitation of health data for profit via platform organizations 
(Ajana 2017). Nevertheless, privacy advocates further perpetuate the 
binary thinking of what is sold for profit by privately held platforms 
versus what could be used for public good. That is, vexing issues 
persist about not only putting one’s private health data in the hands of 
platforms which then sell it to pharmaceuticals and research institutions 
that may have a vested interest exclusive of the interest of the society 
at large. There also continue to persist security issues related to data 
hacking and scraping, and data discrimination.  
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While such concerns are legitimate, they are contingent and 
contextual. We are in the midst of a world health and sanitary crisis, 
and in such contingencies, sharing of data and data philanthropy 
(Tatevossian 2011) by platforms become ever more important if used 
for the purposes of science and public health and under full protection 
of civil rights. Decentralization of biosocial surveillance makes health 
data sharing a shared responsibility and liability including all the 
stakeholders involved. What is required of us is to clearly identify these 
responsibilities for not only data for good but also privacy for good, 
ensuring data security and preventing manipulation of data by macro 
institutions, and managing patient literacy as they increasingly become 
bio digital citizens (Petersen 2018) for sharing, surveilling, and 
generating medical knowledge, hence influencing science.  
Furthermore, reinstalling people’s trust in governmental 
agencies for protecting citizen rights and civil liberties and eradicating 
the belief that these rights and liberties are not traded for public health 
will be vital, and complete transparency and precision is required 
regarding the use, aim, and sharing of patient data (Kitchin 2020). To 
ensure that the use of technologies for collecting patient data is 
deployed safely and responsibly for public good, UN Global Pulse, an 
initiative by United Nations Secretary General, established a network 
platform of companies, academics and research institutions, UN 
agencies and member states in order to apply advanced analytics and 
artificial intelligence to manage infodemic, develop predictive systems 
to model the spread of the virus and how it influences public health 
decisions, identify the overall impact of the epidemic on areas such as 
food security, education and access to healthcare, and deploy the best 
data governance practices. Such initiatives will be important for the 
legitimation and reinforcement of biosocial surveillance in the best 
interest of patient citizens and public health. 
7
Vicdan: Platformization of COVID
Published by DigitalCommons@URI, 2020
References  
Ajana, Btihaj (2017), “Digital Health and the Biopolitics of the 
Quantified Self,” Digital Health, 3, 1-18. 
https://doi.org/10.1177/2055207616689509  
Albrechtslund, Anders (2008), “Online Social Networking as 
Participatory Surveillance,” First Monday 13 (3) (accessed on 
December 15, 2020. [available at: 
https://firstmonday.org/article/view/2142/1949]  
Beer, David (2009), “Power through the algorithm? Participatory Web 
Cultures and the Technological Unconscious,” New Media & 
Society, 11, 985-1002.  
https://doi.org/10.1177/1461444809336551  
Donovan, Joan (2020), “Here’s how Social Media can Combat the 
Coronavirus ‘Infodemic’,” MIT Technology Review, (accessed on 
June 15, 2020), [available at: 
https://www.technologyreview.com/2020/03/17/905279/facebook
-twitter-social-media-infodemic-misinformation] 
Epstein, Charlotte (2006), Guilty Bodies, Productive Bodies, 
Destructive Bodies: Crossing the Biometric Borders, 
International Studies Association Conference. 
Foucault, Michel (1980), “Truth and Power”, in Gordon, Colin (ed.), 
Power/Knowledge: Selected Interviews and Other Writings 
1972-1977 by Michel Foucault, 109-33. 
——— (1990), The History of Sexuality. New York: Vintage Books. 
——— (2003), Society Must be Defended: Lectures at the College de 
France, 1975-1976. New York: Picador. 
French, Martin, and Torin Monahan (2020), “Dis-ease Surveillance: 
How might Surveillance Studies Address COVID-19?” 
Surveillance & Society, 18 (1), 1-11. 
https://doi.org/10.24908/ss.v18i1.13985  
Gibbon, Sahra and Carlos Novas (2008), “Introduction,” in 
Biosocialities, Genetics and the Social Sciences –Making 
Biologies and Identities. London: Routledge. 
Gillespie, Tarleton (2010), The Politics of “Platforms,” New Media & 
Society, 12, 347-64. https://doi.org/10.1177/1461444809342738  
Haggerty, Kevin D. and Richard V. Ericson (2000), “The Surveillant 
Assemblage,” British Journal of Sociology, 51 (4), 605−22. 
https://doi.org/10.1080/00071310020015280  
Helmond, Anne (2015), “The Platformization of the Web: Making Web 
Data Platform Ready,” Social Media and Society, 1 (2), 
https://doi.org/10.1177/2056305115603080  
Hiley, David R. (1984), “Foucault and the Analysis of Power: Political 
Engagement without Liberal Hope or Comfort,” Praxis 
International, 4 (2), 192-207. 
8
Markets, Globalization & Development Review, Vol. 5 [2020], No. 3, Art. 2
https://digitalcommons.uri.edu/mgdr/vol5/iss3/2
DOI: 10.23860/MGDR-2020-05-03-02
Joshi, Aditya, Ross Sparks, James McHugh, Sarvnaz Karimi, Cecile 
Paris and Raina MacIntyre (2020), “Harnessing Tweets for the 
Early Detection of an Acute Disease Event,” Epidemiology, 31 
(1), 90−97, https://doi.org/10.1097/EDE.0000000000001133  
Kitchin, Rob (2020), “Civil Liberties or Public Health, or Civil Liberties 
and Public Health? Using Surveillance Technologies to Tackle 
the Spread of COVID-19,” Space and Polity, 362-81 
https://doi.org/10.1080/13562576.2020.1770587   
Knight, Will (2020), “How AI is Tracking the Coronavirus Outbreak,” 
Wired, (accessed on February 8, 2020), [available at: 
https://www.wired.com/story/how-ai-tracking-coronavirus-
outbreak/]  
Lyon, David (2006), “The Search for Surveillance Theories,” in D. Lyon 
(Ed.), Theorising Surveillance: The Panopticon and Beyond, 3-20, 
Portland: Willan Publishing.  
Lupton, Deborah (2014), “Quantified Sex: A Critical Analysis of Sexual 
and Reproductive Self-tracking Using Apps,” Cult Health Sex, 
17, 1-14. https://doi.org/10.1080/13691058.2014.920528  
Ozgun, Aras (2018), "[Cntrl] + [Alt] + [Esc] ? Virtual Platforms as 
Spaces of Control and Contestation," Markets, Globalization & 
Development Review, 3 (3), https://doi.org/10.23860/MGDR-
2018-03-03-01  
Petersen, Alan (2018), Digital Health and Technological Promise: A 
Sociological Inquiry. Abingdon, Oxon: Routledge. 
Rabinow, Paul (1996), Artificiality and Enlightenment: From 
Sociobiology to Biosociality: Essays on the Anthropology of 
Reason. Princeton University Press: NJ. 
Rose, Nikolas (2007), The Politics of Life Itself: Biomedicine, Power, 
and Subjectivity in the Twenty-First Century. Princeton 
University Press: NJ. 
Tatevossian, Anoush Rima (2011), “Data Philanthropy: Public & Private 
Sector Data Sharing for Global Resilience,” UN Global Pulse, 
(accessed on December 16, 2020), [available at: 
https://www.unglobalpulse.org/2011/09/data-philanthropy-public-
private-sector-data-sharing-for-global-resilience/] 
Van Dijck, José (2013), The Culture of Connectivity: A Critical History 
of Social Media. Oxford and New York: Oxford University Press. 
Zuboff, Shoshana (2019), The Age of Surveillance Capitalism: The 




Vicdan: Platformization of COVID
Published by DigitalCommons@URI, 2020
